Doxazosin 8mg: Comprehensive Guide to Uses, Side Effects, and Dosing
What are the primary uses of Doxazosin. How does Doxazosin work to treat hypertension and BPH. What are the common side effects of Doxazosin. How should Doxazosin be taken for optimal results. What precautions should be considered when using Doxazosin.
Understanding Doxazosin: An Overview of Its Uses and Mechanisms
Doxazosin is a versatile medication that plays a crucial role in treating two common health conditions: hypertension and benign prostatic hyperplasia (BPH). As an alpha-blocker, this drug works by relaxing blood vessels and specific muscles in the body, providing relief for patients struggling with high blood pressure or prostate-related issues.
Doxazosin for Hypertension Management
In the realm of cardiovascular health, Doxazosin stands out as an effective treatment for hypertension. By relaxing blood vessels, it allows for improved blood flow throughout the body, thus reducing blood pressure. This mechanism not only helps in managing daily blood pressure levels but also plays a significant role in preventing serious health complications.
- Reduces risk of strokes
- Helps prevent heart attacks
- Protects kidney function
Doxazosin in BPH Treatment
For men dealing with the uncomfortable symptoms of an enlarged prostate, Doxazosin offers a targeted approach. Unlike treatments that aim to shrink the prostate, this medication focuses on relaxing the muscles in the prostate and bladder area. This action provides relief from common BPH symptoms, improving quality of life for many patients.
- Eases difficulty in initiating urination
- Improves urine flow strength
- Reduces frequency and urgency of urination, including nocturia
Dosage and Administration: Maximizing Doxazosin’s Effectiveness
Proper administration of Doxazosin is crucial for achieving optimal results while minimizing potential side effects. The medication is typically taken orally, with or without food, as directed by a healthcare professional.
Initial Dosing and Titration
To mitigate the risk of sudden blood pressure drops, doctors usually start patients on a low dose of Doxazosin and gradually increase it. This approach, known as dose titration, allows the body to adjust to the medication’s effects.
- Start with a low dose, often 1mg daily
- Gradually increase dose based on patient response and tolerance
- Typical maintenance dose ranges from 4mg to 8mg daily
Timing and Consistency in Doxazosin Administration
Consistency in taking Doxazosin is key to maintaining its therapeutic effects. Patients are typically advised to take the medication at the same time each day to establish a routine and ensure steady blood levels of the drug.
Are there specific times of day when Doxazosin should be taken. The initial dose is often recommended to be taken at bedtime to minimize the risk of dizziness or fainting. As treatment progresses, the timing may be adjusted based on individual response and lifestyle factors.
Navigating Potential Side Effects of Doxazosin
While Doxazosin is generally well-tolerated, being aware of potential side effects is crucial for patients and healthcare providers alike. Understanding these effects can help in early identification and management, ensuring the best possible treatment outcomes.
Common Side Effects
Many patients experience mild side effects that often subside as the body adjusts to the medication. These may include:
- Dizziness
- Lightheadedness
- Drowsiness
- Unusual tiredness
- Slight weight gain
How can patients manage these common side effects. Simple strategies like rising slowly from sitting or lying positions can help mitigate dizziness and lightheadedness. Staying well-hydrated and maintaining a balanced diet may also alleviate some of these effects.
Serious Side Effects Requiring Immediate Attention
While less common, some side effects warrant immediate medical attention. Patients should be vigilant for:
- Persistent sore throat
- Fainting episodes
- Shortness of breath
- Unusual weakness
- Swelling in hands or feet
- Signs of liver problems (yellowing eyes/skin, dark urine)
- Easy bleeding or bruising
- Unexplained fever
In rare cases, male patients may experience a prolonged and painful erection lasting 4 hours or more, a condition known as priapism. This requires immediate medical intervention to prevent long-term complications.
Interactions and Precautions: Ensuring Safe Use of Doxazosin
The effectiveness and safety of Doxazosin can be influenced by various factors, including other medications and pre-existing health conditions. Understanding these interactions and taking necessary precautions is essential for optimal treatment outcomes.
Drug Interactions
Doxazosin may interact with several other medications, potentially altering its effectiveness or increasing the risk of side effects. Some notable interactions include:
- Phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil)
- Other alpha-blockers
- Certain antihypertensive medications
- Some antidepressants
How can patients ensure they’re not at risk for drug interactions. It’s crucial to provide a comprehensive list of all medications, including over-the-counter drugs and supplements, to healthcare providers. Regular medication reviews can help identify and manage potential interactions effectively.
Medical History Considerations
Certain pre-existing conditions may affect the suitability of Doxazosin as a treatment option. Patients should inform their healthcare providers about any history of:
- Heart disease (e.g., congestive heart failure, angina)
- Liver problems
- Kidney disease
- Prostate cancer
- Low blood pressure
- Planned eye surgery
These conditions may necessitate dosage adjustments, additional monitoring, or alternative treatment approaches to ensure patient safety.
Long-Term Management and Monitoring with Doxazosin
Effective long-term use of Doxazosin requires ongoing management and regular monitoring to ensure continued efficacy and safety. This collaborative approach between patients and healthcare providers is crucial for optimizing treatment outcomes.
Regular Check-ups and Assessments
Patients on Doxazosin should undergo regular medical evaluations to assess the medication’s effectiveness and monitor for any potential side effects or complications. These check-ups typically involve:
- Blood pressure measurements
- Prostate examinations (for BPH patients)
- Liver and kidney function tests
- Assessment of symptom improvement
How frequently should these check-ups occur. Initially, more frequent visits may be necessary, especially during dose adjustments. As treatment stabilizes, the frequency may decrease, but regular monitoring remains important for long-term success.
Lifestyle Modifications to Complement Doxazosin Treatment
While Doxazosin can be highly effective, combining medication with lifestyle changes can enhance overall treatment outcomes. Patients are often encouraged to:
- Maintain a healthy diet low in sodium and rich in fruits and vegetables
- Engage in regular physical activity as approved by their healthcare provider
- Limit alcohol consumption
- Quit smoking
- Manage stress through relaxation techniques or counseling
These lifestyle modifications not only support the effectiveness of Doxazosin but also contribute to overall cardiovascular health and prostate well-being.
Patient Education: Empowering Informed Decision-Making
Educating patients about Doxazosin is a crucial aspect of successful treatment. Well-informed patients are better equipped to manage their medication regimen, recognize potential issues, and communicate effectively with their healthcare providers.
Understanding the Importance of Adherence
Consistent adherence to the prescribed Doxazosin regimen is vital for achieving and maintaining therapeutic benefits. Patients should be educated on:
- The long-term nature of the treatment
- The importance of taking medication even when feeling well
- Strategies for remembering to take doses regularly
- What to do if a dose is missed
Why is adherence particularly important with Doxazosin. Unlike some medications that provide immediate symptomatic relief, the full benefits of Doxazosin may take several weeks to become apparent. Consistent use is necessary to maintain these benefits and prevent complications associated with untreated hypertension or BPH.
Recognizing and Reporting Side Effects
Patients should be well-versed in identifying potential side effects and understanding which warrant medical attention. This knowledge empowers them to:
- Distinguish between common, transient side effects and more serious symptoms
- Know when and how to report side effects to their healthcare provider
- Understand the importance of not discontinuing medication without medical advice
Encouraging open communication between patients and healthcare providers can lead to better management of side effects and improved overall treatment outcomes.
Doxazosin in Special Populations: Tailoring Treatment Approaches
While Doxazosin is widely used, its application in certain patient groups requires special consideration. Understanding these nuances is crucial for healthcare providers in tailoring treatment plans to individual patient needs.
Doxazosin in Elderly Patients
Older adults may be more sensitive to the effects of Doxazosin, particularly its blood pressure-lowering action. Special considerations for this population include:
- Starting with lower initial doses
- More gradual dose titration
- Closer monitoring for orthostatic hypotension
- Assessing fall risk and implementing preventive measures
How does age affect the pharmacokinetics of Doxazosin. Elderly patients may have altered drug metabolism and elimination rates, potentially leading to higher blood concentrations of the medication. This underscores the need for individualized dosing and vigilant monitoring in this population.
Doxazosin in Patients with Renal or Hepatic Impairment
Patients with kidney or liver dysfunction may require dosage adjustments or alternative treatment strategies. Considerations include:
- Assessing the degree of organ impairment
- Monitoring drug levels and response more closely
- Potential need for reduced dosages or extended dosing intervals
- Evaluating the risk-benefit ratio in severe cases of organ dysfunction
Regular liver and kidney function tests may be necessary to ensure safe and effective use of Doxazosin in these patient groups.
Doxazosin Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing
Uses
Doxazosin is used alone or with other drugs to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication works by relaxing blood vessels so blood can flow more easily.Doxazosin is also used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and part of the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night).Doxazosin belongs to a class of drugs known as alpha blockers.
How to use doxazosin oral
Read the Patient Information Leaflet if available from your pharmacist before you start taking doxazosin and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
Take this medication by mouth with or without food as directed by your doctor, usually once daily.
Doxazosin may cause a sudden drop in your blood pressure, which could lead to dizziness or fainting, usually within 2 to 6 hours after you take it. This risk is higher when you first start taking this drug, after your doctor increases your dose, or if you restart treatment after you stop taking it. During these times, avoid situations where you may be injured if you faint.
To avoid injury related to dizziness or fainting, take your first dose of doxazosin at bedtime unless otherwise directed by your doctor. Your doctor will start this medication at a low dose and gradually increase your dose. Any time your dose is increased or if you restart treatment after you have stopped it, take your first dose at bedtime unless otherwise directed. Follow your doctor’s instructions carefully.
The dosage is based on your medical condition and response to treatment.
Take this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day. If you miss taking doxazosin for a few days, you may need to restart treatment at the low dose and gradually increase your dose again. Consult your doctor for more details.
Keep taking this medication even if you feel well. Most people with high blood pressure do not feel sick.
You should see a benefit from this drug within 1 to 2 weeks. Tell your doctor if your condition does not improve or if it worsens (for example, your blood pressure readings remain high or increase, or your BPH symptoms worsen).
Side Effects
Dizziness, lightheadedness, drowsiness, unusual tiredness, or weight gain may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
To reduce the risk of dizziness and lightheadedness, get up slowly when rising from a sitting or lying position.
Remember that this medication has been prescribed because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Tell your doctor right away if you have any serious side effects, including: sore throat that doesn’t go away, fainting, shortness of breath, weakness, swelling of hands/feet, yellowing eyes/skin, dark urine, easy bleeding/bruising, fever.
Get medical help right away if you have any very serious side effects, including: chest pain.
Rarely, males may have a painful or prolonged erection lasting 4 or more hours. If this occurs, stop using this drug and get medical help right away, or permanent problems could occur.
A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US – Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
In Canada – Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Precautions
Before taking doxazosin, tell your doctor or pharmacist if you are allergic to it; or to other alpha blockers such as prazosin or terazosin; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: heart disease (such as congestive heart failure, angina, heart attack in last 6 months), liver disease, certain eye problems (cataracts, glaucoma).
This drug may make you dizzy or drowsy. Alcohol or marijuana (cannabis) can make you more dizzy or drowsy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis). See also How to Use section.
Before having surgery (including cataract/glaucoma eye surgery), tell your doctor or dentist if you are taking or have ever taken this medication, and about all the other products you use (including prescription drugs, nonprescription drugs, and herbal products).
Older adults may be more sensitive to the side effects of this drug, especially dizziness and low blood pressure when getting up from a sitting or lying position. These side effects can increase the risk of falling.
During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.
This drug passes into breast milk. Consult your doctor before breast-feeding.
Interactions
Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor’s approval.
Some products that may interact with this drug include: other alpha blocker drugs (such as prazosin, tamsulosin).
If you are also taking a drug to treat erectile dysfunction-ED or pulmonary hypertension (such as sildenafil, tadalafil), your blood pressure may get too low which can lead to dizziness or fainting. Your doctor may need to adjust your medications to minimize this risk.
Other medications can affect the removal of doxazosin from your body, which may affect how doxazosin works. Examples include azole antifungals (such as itraconazole, ketoconazole), macrolide antibiotics (such as clarithromycin), HIV protease inhibitors (such as lopinavir), ritonavir, among others.
Some products have ingredients that could raise your blood pressure. Tell your pharmacist what products you are using, and ask how to use them safely (especially cough-and-cold products, diet aids, or NSAIDs such as ibuprofen/naproxen).
Does doxazosin oral interact with other drugs you are taking?
Enter your medication into the WebMD interaction checker
Overdose
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center. Symptoms of overdose may include: severe dizziness, fainting, weakness.
Do not share this medication with others.
If you have high blood pressure, lifestyle changes that may help this medication work better include exercising, stopping smoking, and eating a low-cholesterol/low-fat diet. Consult your doctor for more details.
Have your blood pressure checked regularly while taking this medication. Learn how to monitor your own blood pressure at home, and share the results with your doctor.
Lab and/or medical tests (such as prostate exams, blood pressure) should be done while you are taking this medication. Keep all medical and lab appointments. Consult your doctor for more details.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up. See also How to Use section.
Store at room temperature away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company.
Images
doxazosin 2 mg tablet
Color: yellowShape: oblongImprint: CARDURA 2 mg
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 8 mg tablet
Color: greenShape: oblongImprint: CARDURA 8 mg
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 8 mg tablet
Color: whiteShape: oblongImprint: APO 096
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 4 mg tablet
Color: whiteShape: oblongImprint: APO 095
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 2 mg tablet
Color: whiteShape: roundImprint: AC 357
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 4 mg tablet
Color: orangeShape: oblongImprint: CARDURA 4 mg
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 2 mg tablet
Color: whiteShape: oblongImprint: APO 094
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 1 mg tablet
Color: whiteShape: roundImprint: APO 093
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 4 mg tablet
Color: whiteShape: diamondImprint: 596 TV
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 8 mg tablet
Color: purpleShape: roundImprint: M D12
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 8 mg tablet
Color: whiteShape: roundImprint: TV 598 8
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 1 mg tablet
Color: whiteShape: oblongImprint: CARDURA 1 mg
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 1 mg tablet
Color: whiteShape: roundImprint: M D9
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 1 mg tablet
Color: whiteShape: roundImprint: 590 TV
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 2 mg tablet
Color: whiteShape: oblongImprint: 593 TV
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 2 mg tablet
Color: creamShape: roundImprint: C 7
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 4 mg tablet
Color: light pinkShape: oblongImprint: 785
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 2 mg tablet
Color: light pinkShape: roundImprint: 784
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 1 mg tablet
Color: whiteShape: roundImprint: 783
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 4 mg tablet
Color: blueShape: roundImprint: M D11
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 1 mg tablet
Color: whiteShape: roundImprint: C 3
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 4 mg tablet
Color: whiteShape: roundImprint: AC 358
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 1 mg tablet
Color: whiteShape: oblongImprint: AC356
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 2 mg tablet
Color: pinkShape: roundImprint: M D10
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 4 mg tablet
Color: orangeShape: ovalImprint: 4 mg ML-P18
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 8 mg tablet
Color: purpleShape: roundImprint: 786
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 8 mg tablet
Color: whiteShape: oblongImprint: AC359
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 8 mg tablet
Color: whiteShape: roundImprint: C 5
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
doxazosin 4 mg tablet
Color: creamShape: roundImprint: C 4
This medicine is a yellow, oblong, scored, tablet imprinted with “CARDURA” and “2 mg”.
Next
Save up to 80% on your prescriptions.
Available coupons
Save up to 80% on your prescription with WebMDRx
Drug Survey
Are you currently using doxazosin oral?
This survey is being conducted by the WebMD marketing sciences department.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.
How and when to take doxazosin
Doxazosin comes as 2 different types of tablet, standard and slow-release. Slow-release tablets release the doxazosin gradually.
Dosage and strength
Standard doxazosin tablets come as 1mg, 2mg, 4mg and 8mg strengths.
Slow-release tablets come as 4mg and 8mg strengths.
How much you take depends on why you need doxazosin and the type of tablet you’re taking.
The usual dose for high blood pressure is:
- standard tablets – 2mg to 16mg, taken once a day
- slow-release tablets – 4mg or 8mg, taken once a day
The usual dose for an enlarged prostate gland is:
- standard tablets – 2mg to 8mg, taken once a day
- slow-release tablets – 4mg or 8mg, taken once a day
You may have to take more than 1 tablet to make up your dose (for example, 2 of the 8mg tablets to make up a 16mg dose). Your doctor will tell you how many tablets to take each day.
Changes to your dose
Your doctor will start you on a lower dose.
If you’re taking standard tablets, your doctor will usually start you on 1mg. They will gradually increase your dose until your condition is under control.
With slow-release tablets, your doctor will usually start you on 4mg and this may be increased to 8mg.
How to take it
Take your doxazosin tablets with a glass of water. Swallow them whole. Do not chew them.
You can take both types of tablet with or without food.
You can take doxazosin in the morning or evening, but it’s best to take it at the same time each day.
Some standard tablets have a score line to help you break the tablet and make it easier to swallow. Check your medicine’s information leaflet to see if you can do this.
How long to take it for
Usually, treatment with doxazosin is long term, even for the rest of your life.
Talk to your doctor if you want to stop taking doxazosin. Suddenly stopping can make your condition worse.
If you are bothered by side effects, your doctor may be able to prescribe a different medicine for your blood pressure or enlarged prostate.
Once you’ve stopped, it’ll take 4 to 5 days for it to be completely out of your body.
If you forget to take it
If you miss a dose of doxazosin, skip the missed dose. Take the next dose at the usual time. Do not take 2 doses to make up for a forgotten dose.
If you forget doses often, it may help to set an alarm to remind you. You could also ask your pharmacist for advice on other ways to help you remember to take your medicine.
If you take too much
Taking too much doxazosin can reduce your blood pressure and increase your heart rate.
Urgent advice: Contact 111 for advice now if:
- you take more than your prescribed dose of doxazosin and feel drowsy, faint or light-headed
Go to 111.nhs.uk or call 111
If you need to go to A&E do not drive yourself. Get someone else to drive you, or call an ambulance.
Take the doxazosin packet, or the leaflet inside it, with you, plus any remaining medicine.
Page last reviewed: 2 March 2022
Next review due: 2 March 2025
Doxazosin tablets 1 mg tablets Health
Composition:
active ingredient: doxazosin;
1 tablet contains doxazosin mesilate in terms of doxazosin 1 mg, 2 mg, or 4 mg;
excipients: microcrystalline cellulose; lactose monohydrate, corn starch; calcium stearate.
Dosage form
Tablets.
basic physical and chemical properties: white tablets with biconvex surface.
Pharmacotherapeutic group
Antihypertensive agents. Antiadrenergic drugs with a peripheral mechanism of action. Blockers of α-adrenergic receptors.
ATC code С02С А04.
Pharmacological properties
Pharmacodynamics.
Mechanism of action
Doxazosin is a potent and selective α1-adrenergic postsynaptic antagonist. Blocking these receptors leads to a decrease in systemic blood pressure. Doxazosin is intended for oral administration once a day in patients with essential arterial hypertension.
Pharmacodynamic effects
Doxazosin has not been shown to cause undesirable metabolic effects and can be used in patients with diabetes mellitus, gout or insulin resistance.
Doxazosin can be administered to patients with bronchial asthma, left ventricular hypertrophy and elderly patients. The use of the drug helps to reduce left ventricular hypertrophy, inhibits platelet aggregation and enhances the activity of tissue plasminogen activator. In addition, the use of doxazosin increases insulin sensitivity in those patients in whom such sensitivity is impaired.
It has also been reported that, in addition to its antihypertensive effect, doxazosin causes a modest decrease in plasma levels of total cholesterol, low-density lipoproteins and triglycerides, and therefore this drug may be especially useful in patients with arterial hypertension and hyperlipidemia.
The use of doxazosin in patients with symptomatic BPH leads to a significant improvement in urodynamics and a decrease in the severity of symptoms. It is believed that the effect of the drug in BPH is achieved by selective blockade of α1-adrenergic receptors located in the muscle stroma and prostate capsule, as well as in the bladder neck.
Pharmacokinetics.
Absorption
When administered orally to humans (young males or older adults of either sex), doxazosin is rapidly absorbed with a bioavailability of about ⅔ doses.
Biotransformation/elimination
Approximately 98% of doxazosin binds to plasma proteins. It has been found that doxazosin is extensively metabolized in the human body and in the studied experimental animals, and is excreted from the body mainly with feces.
The mean half-life (T½) of the drug from blood plasma is 22 hours, which makes it possible to take the drug once a day.
When doxazosin is administered orally, plasma levels of the drug’s metabolites are low. The plasma concentration of the active metabolite 6′-hydroxydoxazosin in humans is 40 times lower than the plasma concentration of the primary compound, which indicates that the antihypertensive effect of the drug is due mainly to doxazosin.
Currently, there are only limited data on the use of the drug in patients with impaired liver function and on the effect of drugs that can alter hepatic metabolism (eg, cimetidine). As with other drugs that are completely metabolized by the liver, doxazosin should be used with extreme caution in patients with signs of hepatic impairment.
Clinical characteristics
Indications
Arterial hypertension. The drug is indicated for the treatment of arterial hypertension and for most patients it can be used to control blood pressure as monotherapy. In case of ineffectiveness of monotherapy for the treatment of arterial hypertension, the drug can be used in combination with thiazide diuretics, β-adrenergic receptor blockers, calcium channel blockers and angiotensin-converting enzyme inhibitors.
Benign prostatic hyperplasia. The drug is indicated for the treatment of urinary tract obstruction, as well as symptoms associated with benign prostatic hyperplasia (BPH). The drug can be prescribed to patients with BPH both in the presence of arterial hypertension and in normal blood pressure.
Contraindications
Hypersensitivity to the active substance or to quinazoline derivatives (eg prazosin, terazosin, doxazosin) or to any of the excipients of the drug listed in the Composition section; history of orthostatic hypotension; BPH and concomitant upper urinary tract obstruction, chronic urinary tract infections and the presence of bladder stones; during lactation (only when used to treat arterial hypertension (see section “Use during pregnancy or lactation”), arterial hypotension (applies only to patients with BPH). Doxazosin as monotherapy is contraindicated in patients with bladder overflow or anuria with with or without progressive renal failure.
Interactions with other medicinal products and other types of interactions
Phosphodiesterase-5 inhibitors (eg sildenafil, tadalafil, vardenafil). Co-administration of doxazosin with PDE-5 inhibitors may cause symptomatic hypotension in some patients. Studies of doxazosin in dosage forms with a long release of the active substance have not been conducted.
Doxazosin is highly bound to plasma proteins (98%). The results of an in vitro study using human plasma indicate that the drug does not affect the binding of the studied drugs (digoxin, phenytoin, warfarin or indomethacin) to proteins.
There were no adverse interactions with the simultaneous use of doxazosin and thiazide diuretics, furosemide, β-adrenergic blockers, non-steroidal anti-inflammatory drugs, antibiotics, oral hypoglycemic agents, uricosuric agents and anticoagulants. However, data from formal drug interaction studies are lacking.
Doxazosin potentiates the hypotensive effect of other α-blockers, as well as other antihypertensive agents.
There is evidence that a single dose of doxazosin at a dose of 1 mg on the first day of a four-day course of oral cimetidine (400 mg 2 times a day) led to an increase in the mean AUC of doxazosin by 10% and did not cause any statistically significant changes in mean Cmax and mean T½ of doxazosin. This 10% increase in doxazosin mean AUC with cimetidine is within the intersubject variability (27%) of doxazosin mean AUC compared with placebo.
Application features.
Orthostatic hypotension/syncope. Start of therapy. As with other α-adrenergic blockers, orthostatic hypotension with doxazosin develops in a very small percentage of patients, manifesting as dizziness and weakness or, less commonly, loss of consciousness (syncope), especially at the beginning of therapy. In this regard, at the beginning of therapy, it is necessary to control the level of blood pressure in order to minimize possible postural effects.
When prescribing therapy with any effective α-adrenergic blocker, inform the patient how to avoid symptoms of orthostatic hypotension and how to behave when they occur. The patient should also be warned to avoid situations in which there is a risk of injury, given the possibility of dizziness or weakness at the beginning of doxazosin therapy.
Use in acute cardiac conditions. As with other vasodilatory antihypertensive agents, doxazosin should be used with caution in patients with the following acute cardiac conditions:
pulmonary edema due to aortic or mitral stenosis;
hypersystolic heart failure;
right heart failure due to pulmonary embolism or pericardial effusion;
left ventricular heart failure with low filling pressure.
Use in violation of liver function. As with other drugs that are completely metabolized by the liver, doxazosin should be administered with extreme caution to patients with signs of hepatic impairment. Due to the lack of clinical experience with the use of the drug in patients with severe liver dysfunction, the appointment of the drug in this category of patients is not recommended.
Use with PDE-5 inhibitors. Doxazosin should be used with caution with phosphodiesterase-5 inhibitors (eg, sildenafil, tadalafil, and vardenafil) because these drugs cause vasodilation and may therefore cause symptomatic hypotension in some patients. To reduce the risk of developing orthostatic hypotension, it is recommended to start therapy with drugs from the phosphodiesterase-5 inhibitor group only if the patient has stable hemodynamics against the background of the use of α-blockers. In addition, it is recommended to start therapy with phosphodiesterase-5 inhibitors at the lowest possible dose and maintain a 6-hour interval between the use of doxazosin and phosphodiesterase-5 inhibitors.
For use in patients undergoing cataract surgery. Some patients who took tamsulosin at the time of cataract surgery or before surgery developed intraoperative atonic iris syndrome (ISARO, a variant of small pupil syndrome) during the procedure. Separate cases of the development of such a side effect have been reported with the use of other α1-blockers, so the possibility of the development of this effect for other drugs of this class of drugs cannot be ruled out. Because ISARO can lead to an increased rate of procedural complications during surgery, ophthalmic surgeons should be informed in preparation for surgery if the patient is using or has used α1-adrenergic receptor blockers.
Priapism. There are reports of cases of prolonged erection and priapism. In the event of an erection that lasts more than 4 hours, the patient should immediately seek medical attention. If priapism is not treated immediately, damage to the tissue of the penis occurs, which can lead to irreversible loss of potency.
Screening for prostate cancer. Prostate carcinoma causes many of the symptoms associated with BPH, and the two conditions can coexist. Therefore, the presence of prostate carcinoma should be ruled out before initiating doxazosin therapy for symptoms of BPH.
The preparation contains lactose. If the patient has an intolerance to some sugars, it is necessary to consult a doctor before taking this drug.
Use during pregnancy or lactation.
Patients with arterial hypertension.
Pregnancy
Due to the current lack of adequate and well-controlled studies on the use of the drug in pregnant women, the safety of the use of doxazosin during pregnancy remains unknown. Therefore, the drug should be used only when the potential benefits of treatment, in the opinion of the doctor, justify the potential risk. Although there is evidence that the drug was not teratogenic in animal studies, its use at very high doses, which are about 300 times higher than the maximum recommended human dose, led to a decrease in fetal life expectancy.
Lactation
The use of doxazosin during lactation is contraindicated because there is evidence that animal studies have shown that doxazosin accumulates in the milk of rats during lactation, and because there is no data on excretion of doxazosin into milk during lactation. breastfeeding in humans. If you need to use doxazosin, you should stop breastfeeding.
Patients with BPH.
The information in this section does not apply to patients with BPH.
The ability to influence the reaction rate when driving vehicles or operating other mechanisms.
The ability to drive and use machines may be impaired, especially at the start of treatment.
Dosage and administration
Doxazosin can be taken both in the morning and in the evening.
The drug is used orally.
Arterial hypertension. The drug should be used 1 time per day. The initial dose is 1 mg to minimize the risk of orthostatic hypotension and/or syncope. After 1-2 weeks of initial therapy, the dose can be increased to 2 mg, and then, if necessary, to 4 mg. In most patients, response to therapy is observed when using the drug at a dose of 4 mg or less. If necessary, the dose can be increased to 8 mg or up to the maximum recommended dose of 16 mg.
Benign prostatic hyperplasia. The recommended starting dose of doxazosin is 1 mg once daily to minimize the risk of orthostatic hypotension and/or syncope. Depending on the individual characteristics of the patient’s urodynamics and symptoms of BPH, the dose can be increased to 2 mg, then to 4 mg and up to the maximum recommended dose of 8 mg. The recommended dose selection interval is 1-2 weeks. The usual recommended dose is 2-4 mg per day.
Elderly patients should use the usual adult doses.
Patients with impaired renal function should use the usual adult doses, since the pharmacokinetic parameters of the drug do not change with impaired renal function.
Doxazosin is not eliminated from the body by hemodialysis.
Patients with impaired liver function. Currently, information on the use of the drug in patients with impaired liver function and on the effect of drugs that can alter hepatic metabolism (for example, cimetidine) is limited. As with other drugs that are completely metabolized by the liver, patients with signs of impaired liver function should be prescribed the drug with caution.
Children.
The safety and efficacy of the drug in children have not been studied.
Overdose
If an overdose of the drug has led to arterial hypotension, the patient should be urgently placed on his back with his head down. In some cases, other symptomatic measures can be taken.
If symptomatic measures are not sufficient, plasma expanders should be used first in the treatment of shock. After that, if necessary, vasoconstrictor drugs should be used. The state of renal function should be monitored and, if necessary, supportive measures should be taken.
Hemodialysis is not indicated because doxazosin is highly protein bound.
Adverse reactions
Infections and infestations: respiratory tract infections, urinary tract infections.
From the blood and lymphatic system: leukopenia, thrombocytopenia.
From the immune system: allergic reactions.
Metabolic and alimentary disorders: gout, increased appetite, lack of appetite.
Mental disorders: agitation, depression, anxiety, insomnia, nervousness.
From the nervous system: drowsiness, dizziness, headache, stroke, hypesthesia, syncope, tremor, orthostatic dizziness, paresthesia.
On the part of the organ of vision: blurred vision, intraoperative atonic iris syndrome.
On the part of the organs of hearing and balance: vertigo, tinnitus.
From the side of the heart: palpitations, tachycardia, angina pectoris, myocardial infarction, bradycardia, cardiac arrhythmias.
Vascular: arterial hypotension, orthostatic arterial hypotension, hot flashes.
From the respiratory system, chest and mediastinum: bronchitis, cough, shortness of breath, rhinitis, epistaxis, increased existing bronchospasm.
From the gastrointestinal tract: abdominal pain, dyspepsia, dry mouth, nausea, constipation, flatulence, vomiting, gastroenteritis, diarrhea.
From the side of the hepatobiliary system: abnormal liver function tests, cholestasis, hepatitis, jaundice.
From the side of the skin and subcutaneous tissue: itching, skin rash, urticaria, alopecia, purpura.
On the part of the musculoskeletal system and connective tissue: back pain, myalgia, arthralgia, muscle spasms, muscle weakness.
From the kidneys and urinary system: cystitis, urinary incontinence, dysuria, frequent urination, hematuria, polyuria, increased diuresis, urinary disorders, nocturia.
From the reproductive system and mammary glands: impotence, gynecomastia, priapism, retrograde ejaculation.
General disorders and reactions at the injection site: asthenia, chest pain, flu-like symptoms, peripheral edema, body pain, swelling of the face, increased fatigue, general malaise.
Research results: weight gain.
Shelf life
5 years.
Storage conditions
Store in the original container at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
Tablets 1 mg #30 in jars or containers in a box; No. 10×3 in blisters in a box; tablets 2 mg or 4 mg No. 10×2 in blisters in a box.
Vacation category
Prescription.
Manufacturer
Limited Liability Company Pilot Plant GNTsLS or
Limited Liability Company PHARMEX GROUP or
Limited Liability Company Pharmaceutical Company Zdorovye.
Location of the manufacturer and address of the place of its activity
Ukraine, 61057, Kharkiv region, Kharkov city, Vorobieva street, 8.
(Limited Liability Company “Experimental Plant “GNTSLS”)
Ukraine, 08301, Kiev region, Borispol, st. Shevchenko, d. 100.
(Limited Liability Company “PHARMEX GROUP”)
Ukraine, 61013, Kharkiv region, city of Kharkiv, Shevchenko street, 22.
(Limited Liability Company “Pharmaceutical company “Health” )
Doxazosin instructions, price in pharmacies of Ukraine
- Product list
- Instructions
Prices in pharmacies
Analogues
Items: 3
Sorting:
Behind the ratingVid cheapVid expensive
Go to cat
Go to cat
Go to cat
Analogs
Show all
Go to cat
Go to cat
Go to cat
Vіd 9. 20 UAH
Type 103.90 UAH
Type 56.60 UAH
Type 210.30 UAH
Type 181. 90 UAH
Type 186.00 UAH
Type 252.70 UAH
Type 716.50 UAH
Ref 124. 00 UAH
Editorial team
Creation date: 04/27/2021
Update date: 06/28/2023
Stock and release form:
Stock:
- inoculation: doxazosin;
- 1 tablet to replace doxazosin mesylate in reconstitution with doxazosin 1 mg, 2 mg, 4 mg;
- additional speech: cellulose microcrystalline lactose monohydrate, starch corn calcium stearate.
Pharmaceutical form:
Tablets 1 mg No. 30 in polymer jars, 1 jar in a box of tablets 2 mg or 4 mg No. 10 in blisters with polyvinyl chloride and aluminum foil, 2 blisters in box Basic physical and chemical powers: white tablets color, chamfer.
Pharmacological activity:
Pharmacodynamics
Doxazosin is a tension and selective antagonist of postsynaptic α 1 -adrenergic receptors. Blocking of cih receptors to cause a decrease in systemic arterial pressure. Doxazosin prescriptions for oral administration 1 time per day for patients with hypertensive disease.
It has been demonstrated that doxazosin does not cause undesirable metabolic effects and may be effective in patients with diabetes mellitus, gout or insulin resistance.
Doxazosin may be indicated for patients with bronchial asthma, hypertrophy of the left duct and patients with a frail eye. Ingestion of the drug reduces hypertrophy of the left duct, suppresses platelet aggregation and enhances the activity of tissue plasminogen activator. In addition, exposure to doxazosin increases sensitivity to insulin in these patients, in whom such sensitivity is impaired.
It has also been suggested that, as an addition to antihypertensive action, the use of doxazosin leads to a moderate decrease in the concentration of high cholesterol, low concentration lipoproteins and triglycerides in blood plasma, and also – this drug may be especially corrosive to patients with arterial hypertension and hyperlipidemia.
Doxazosin ingestion by patients with symptomatic BPH can lead to a significant increase in urodynamics and a change in symptoms. It is important that the effect of the drug in DGPZ is achieved by the selective blockade of α 1 -adrenergic receptors, rotting in the m’yazovy stroma and capsule of the anterior ridge, as well as in the shiytsa of the sich michur.
Pharmacokinetics
Inoculation. In case of oral ingestion in humans (young people or people of frail age, be it status), doxazosin is easily absorbed with bioavailability at approximately ⅔ of the dose.
Metabolism/elimination. Approximately 98% of doxazosin binds to plasma proteins. It has been shown that doxazosin is extensively metabolized in the human body and in the experimental animals that have been studied, and is excreted in the body most importantly in the feces.
Indications before congestion:
Arterial hypertension. The drug of indications for the treatment of arterial hypertension and for a large number of patients can be used to control arterial pressure in the form of monotherapy. In case of ineffectiveness of monotherapy for the treatment of arterial hypertension, the drug can be combined with thiazide diuretics, β-adrenergic receptor blockers, calcium channel blockers and ACE inhibitors.
Benign hyperplasia of the anterior fold. The drug is indicated for the treatment of obstruction of the sieve passages, as well as symptoms associated with benign hyperplasia of the anterior vulva (DGPZ). The drug can be prescribed to patients with DGPZ, both with evidence of arterial hypertension, and with a normal level of arterial pressure.
Contraindications:
- hypersensitivity to similar quinazolin (e.g. prazosin, terazosin, doxazosin) or to any other drug
- history of orthostatic hypotension
- DGPZ and concomitant obstruction of the upper sieve passages, chronic infections of the sich passages and the presence of stones in the sieve tunic;
- arterial hypotension (there are only a few patients with BPH).
Doxazosin as a monotherapy is contraindicated in patients with relapsing sich michur or anuria due to progressive nirk deficiency or without it.
Dose schedule:
Doxazosin can be taken early or in the evening.
Arterial hypertension. The drug should be taken 1 time per harvest. The initial dose should be 1 mg to reduce the risk of developing orthostatic hypotension to a minimum and / or not to be tired. After 1-2 cycles of cob therapy, the dose can be increased up to 2 mg, and then, as necessary, up to 4 mg. Most patients are eligible for therapy if the drug is taken at a dose of 4 mg or lower. If necessary, the dose may be increased up to 8 mg to the maximum recommended dose of 16 mg.
Benign acid hyperplasia of the anterior fold. The recommended dose of doxazosin is 1 mg once daily to minimize the risk of developing orthostatic hypotension and/or ease of fatigue. Depending on the individual characteristics of the patient’s urodynamics and symptoms of BPH, the dose can be increased up to 2 mg, then up to 4 mg, and up to the maximum recommended dose – 8 mg. The recommended dose selection interval is 1-2 days. The recommended dose is 2-4 mg per dose.
Summer age patients
Patients with impaired function of the drug should be prescribed lower doses for adults, but the pharmacokinetic parameters of the drug with impaired function of the drug do not change.
Doxazosin is not excreted as an aid to hemodialysis.
Patients with impaired liver function. The information about drug administration in patients with impaired liver function and when injecting drugs that alter hepatic metabolism (for example, cimetidine) is exchanged. However, if other drugs are overused, they will be more metabolized in the liver, in patients with signs of impaired liver function, the drug should be considered safe.
Overdose:
As if the overdose has led to hypotension, the patient should be put on his back, with his head down. In other cases, you can take other symptomatic approaches.
Although there are not enough symptomatic visits, plasma exchangers should be blocked to treat shock in the first week. Then, if necessary, follow up with a vessel sound preparation. Follow the camp of the function of the field and, if necessary, zastosovuvat pіdtremuyuchi come in.
Hemodialysis indications, doxazosin shards in a significant world are associated with blood plasma proteins.
Side effects:
Infections and invasions:
From the side of the blood and lymphatic systems: leukopenia, thrombocytopenia.
From the side of the immune system: allergic reactions.
Metabolic and alimentary disorders: gout, increased appetite, increased appetite.
Mental disorders: mental disorders, depression, anxiety, sleeplessness, nervousness.
From the side of the nervous system: drowsiness, confusion, headache, stroke, hypoesthesia, syncope, tremor, orthostatic confusion, paresthesia.
Laterally organ gap: blurred gap, intraoperative atonic iris syndrome.
To the side of the hearing organs and equal: vertigo, noise in the ears.
Heart side: tachycardia, tachycardia, angina pectoris, myocardial infarction, bradycardia, arrhythmia.
To the side of the vessels: arterial hypotension, orthostatic arterial hypotension, flushing.
To the side of the dichal system, thoracic cell and middle wall: bronchitis, cough, rhinitis, nasal bleeding, exacerbation of acute bronchospasm.
To the side of the intestinal tract: pain in the abdomen, dyspepsia, dry mouth, nausea, constipation, flatulence, vomiting, gastroenteritis, diarrhea.
From the side of the herbal system: indications of normal liver function, cholestasis, hepatitis, zhovtyanitsya.
To the lateral side of the shkіr and the under-shkіr plait: sverbіzh, hanging on the shkіrі, kropivyanka, alopecia, purpura.
To the side of the musculoskeletal system and happy tissue: pain on the back, pain on the tongue, pain on the folds, tongue spasms, tongue weakness.
On the side of the sciatica system: cystitis, non-manic suturing, dysuria, frequent suturing, hematuria, polyuria, increased diuresis, derangement of sechovidnja, nocturia.
From the side of the reproductive system and mammary glands: impotence, gynecomastia, priapism, retrograde ejaculation.
Inflammatory disorders and reactions in the area of injection: asthenia, chest pain, flu-like symptoms, peripheral swelling, pain in the body, swelling of the face, increased stupor , burning weakness.
The result of the report: increased body weight.
Plant specifics:
Orthostatic hypotension / syncope. Cob therapy. As with other blockers of α-adrenergic receptors, orthostatic hypotension with vicarious doxazosin develops in the arch of a small number of patients, manifesting as congestion and weakness or, more commonly, as a second syncope (syncope), especially on the beginning of therapy. In connection with cym on the cob of therapy, it is necessary to control the level of the arterial pressure, in order to minimize the possible postural effects.
When prescribing therapy, be it an effective α-adrenergic blocker, inform the patient about the symptoms of orthostatic hypotension and how to behave in case of symptoms. It is also necessary to keep the patient ahead of the need for unique situations, in which case there is a risk of avoiding injuries, looking at the possibility of causing confusion or weakness on the cob of doxazosin therapy.
Zastosuvanya at the heart of the camps. As and other vasodilating antihypertensive diseases, doxazosin is followed by the prevention of congestion in patients with advanced heart disease:
- or mitral stenosis;
- hypersystole heart failure
- right ventricular heart failure associated with thromboembolism of the legenous artery or pericardial effusion;
- left heart failure with low pressure
Stasis due to impaired liver function. Even if other drugs are ingested, they are more likely to be metabolized in the liver, in patients with signs of impaired liver function, doxazosin should be indicated for special care. After a few days of clinical evaluation of the drug in patients with severe hepatic impairment, it is not recommended to administer the drug to this category of patients.
Prescription with PDE-5 inhibitors. Take doxazosin together with phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil and vardenafil) as a precautionary measure; be able to overcome symptomatic hypotension in some patients. In order to reduce the risk of developing orthostatic hypotension, it is recommended to start therapy with drugs of the phosphodiesterase-5 inhibitor group for a wash, as if the aphids are blocked by α-blockers, the patient may have stable hemodynamics. In addition, it is recommended to initiate therapy with phosphodiesterase-5 inhibitors at the lowest possible dose and maintain a 6-year interval between doxazosin and phosphodiesterase-5 inhibitors.
Patients for an hour of cataract surgery. In some patients who took tamsulosin for one hour of cataract surgery, or before surgery, for the first hour of the operation, the development of intraoperative atonic iris syndrome (“IFIS” – syndrome of the iris zіnitsi). It was mentioned about the occurrence of such a side effect when other α 1 blockers were taken, this cannot be excluded from the possibility of developing this effect for other drugs in this class of medicinal drugs. So IFIS can lead to an increase in the frequency of procedural complications during the operation, while preparing for it, it is necessary to consult ophthalmologists, stop the patient from blocking α 1 -adrenergic receptors.
Patients with rare contagious ailments, such as galactose intolerance, Lapp lactase deficiency and glucose-galactose malabsorption, not followed by drug congestion .
Special indications:
Congestion during pregnancy and breastfeeding
Patients with arterial hypertension. Through several days of successive and well-controlled follow-up on the elimination of the drug intake of the drug, the prevention of the intake of doxazosin during the period of pregnancy remains unidentified. Therefore, the drug should be zastosovuvaty only once, if the potenciynі perevagi likuvannya, from the point of view of the doctor, the potency risk is true. Wanting to clarify the data that in studies on animals the drug did not show teratogenicity, even in high doses, it exceeded the maximum recommended dose for humans by about 300 times, leading to a decrease in fetal life.
Accumulation of doxazosin during breastfeeding is contraindicated, but there are few data, but studies on animals have shown that doxazosin accumulates in breast milk during lactation, and also there is no evidence of excretion of doxazosin into milk during lactation in humans. If necessary, doxazosin intake should be given to the breast.
Children
I don’t know if there is a problem with children.
The ability to influence the speed of the reaction when caring for vehicles or other mechanisms
The cost of building a car and working with mechanisms can be damaged, especially on the cob of luxuriance.
Interactions with other medical problems and other types of interactions:
Phosphodiesterase-5 inhibitors (eg, sildenafil, tadalafil, vardenafil). Chronic exposure to doxazosin with PDE-5 inhibitors in some patients may result in symptomatic hypotension. Studies of doxazosin in dosage forms have not been carried out for trials of oral speech.
Doxazosin in the world is associated with blood plasma proteins (by 98%). The results of in vitro studies of human blood plasma tests indicate that the drug does not affect the binding of other drugs (digoxin, phenytoin, warfarin or indomethacin) with proteins.
No adverse interactions observed in case of one-hour ingestion of doxazosin and thiazide diuretics, furosemide, β-adrenergic receptor blockers, non-steroidal anti-inflammatory drugs, antibiotics, oral glucocorticosteroids iv, uricosuric effects and anticoagulants. However, there are formal reports on medical interdependence during the day.
Doxazosin has a hypotensive effect on other α-blockers, as well as other antihypertensive effects.
There is evidence that a single ingestion of doxazosin at a dose of 1 mg on the first day of chotiridobove a course of oral ingestion of cimetidine (400 mg 2 times per dose) resulted in a 10% increase in the mean doxazosin AUC and did not decrease any statistically significant changes in the average C max i the middle period of administration of doxazosin. Such a 10% increase in the mean AUC of doxazosin on aphids of cimetidine is in the range of inter-individual variability (27%) of the mean AUC of doxazosin compared with placebo.
Wash safety:
Save in original packaging at temperatures not exceeding 25 °C.
Save in a place inaccessible to children.
The term of appurtenance – 3 years.
Doxazosin instructions
DOXAZOSIN
(UA/2974/01/01)
Release form:
1 mg tablets; 10 tablets in a blister; 3 blisters in a box; 30 tablets per bank or container; 1 bundle or container in a box of cardboard
Stock:
1 tablet to replace doxazosin mesylate in case of reconsideration to doxazosin 1 mg
Manufacturer:
Ukraine
DOXAZOSIN
(UA/2974/01/02)
Release form:
tablets of 2 mg, 10 tablets in a blister; 2 blisters in a box of cardboard
Stock:
1 tablet to replace doxazosin mesylate in case of overdose on doxazosin 2 mg
Manufacturer:
Ukraine
DOXAZOSIN
(UA/2974/01/03)
Release form:
tablets of 4 mg, 10 tablets in a blister; 2 blisters in a box of cardboard
Stock:
1 tablet to replace doxazosin mesylate in case of overdose on doxazosin 4 mg
Manufacturer:
Ukraine
DOXAZOSIN-KV
(UA/10676/01/01)
Release form:
tablets of 2 mg, 10 tablets in a blister; 3 blisters in a pack
Stock:
1 tablet to replace 2 mg doxazosin (for example, doxazosin mesylate)
Manufacturer:
Ukraine
DOXAZOSIN-KV
(UA/10676/01/02)
Release form:
tablets of 4 mg, 10 tablets in a blister; 3 blisters in a pack
Stock:
1 tablet to replace 4 mg doxazosin (externally doxazosin mesylate)
Manufacturer:
Ukraine
Doxazosin price in Pharmacy 911
Name | Price |
---|---|
Doxazosin tab. |